Table 3.

Clinical outcomes

	PH (−) N = 83	PH (+) N = 65	P value	Adjusted OR (95% CI)*	Adjusted P value
In-hospital/30-day
Bleeding	25 (30.1)	24 (36.9)	0.38	1.36 (0.680–2.72)	0.39
Blood transfusion	23 (27.7)	21 (32.3)	0.54	1.24 (0.61–2.54)	0.55
AKI grade 3	2 (2.4)	6 (9.2)	0.14	3.93 (0.76–20.47)	0.10
All-cause death	6 (7.2)	6 (9.2)	0.66	1.29 (0.39–4.22)	0.68
12-month
Myocardial infarction	1 (1.2)	3 (4.6)	0.32	3.53 (0.35–35.92)	0.29
Stroke/TIA	3 (3.6)	7 (10.8)	0.11	2.93 (0.71–12.03)	0.14
New onset AF	3 (3.6)	7 (10.8)	0.11	2.77 (0.66–11.63)	0.16
New permanent pacemaker	15 (18.1)	9 (13.8)	0.49	0.74 (0.30–1.83)	0.52
All-cause death	8 (9.6)	14 (21.5)	0.043	2.39 (0.91–6.24)	0.08
Maximal follow-up
All-cause death	13 (15.7)	20 (30.8)	0.028	2.26 (1.01–5.06)	0.047

AF atrial fibrillation, AKI acute kidney injury, TIA transient ischemic attack

^aDerived from multivariable regression model—adjusted for age/gender